C12Y 203/01074
Naringenin-chalcone synthase , i.e. chalcone synthase
Official title: Naringenin-chalcone synthase (2.3.1.74), i.e. chalcone synthase
C12Y203/01074 (Naringenin-chalcone synthase , i.e. chalcone synthase) appears on 12 US grants and 27 published applications in this corpus.
Search patents in C12Y- Granted patents
- 12
- Published applications
- 27
- Assignees
- 17
- Inventors
- 67
- Latest grant
- 23 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 2 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 3 |
| 2010 | 2 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 1 | 2 |
| 2016 | 1 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 2 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 2 |
| 2022 | 0 | 0 |
| 2023 | 0 | 4 |
| 2024 | 1 | 1 |
| 2025 | 0 | 4 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Microbial polycultures and methods of use thereof23 Apr 2024US 11,965,197 B2Rensselaer Polytechnic Institute
- Microbial polycultures and methods of use thereof23 Mar 2021US 10,954,543 B2Rensselaer Polytechnic Institute
- Biosynthesis of phenylpropanoids and phenylpropanoid derivatives21 May 2019US 10,294,499 B2Evolva SA
- Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof5 Dec 2017US 9,834,793 B2Evolva SA
- Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof2 Aug 2016US 9,404,129 B2Evolva SA
- Method of producing styrylpyrones and chalcones24 Sep 2026US 2026/0286375 A1Nicoventures Trading Limited
- Recombinant host cells with improved production of tetraketide derivatives27 Aug 2026US 2026/0250728 A1Iptector Assets Aps
- Biosynthesis26 Jun 2025US 2025/0207166 A1
- Modified Polyketide Synthase Enzymes and Uses Thereof29 May 2025US 2025/0171750 A1Bgene Genetics
- Method for Regulating and Controlling Heterologous Synthetic Flavonoid Compound and Use Thereof20 Mar 2025US 2025/0092431 A1
Most cited
By later US patents
- Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof6US 8,895,287 B2Evolva SA · 2014
- Production of flavonoids by recombinant microorganisms5US 7,338,791 B2The Research Foundation of State University of New York · 2008
- Biosynthesis of phenylpropanoids and phenylpropanoid derivatives4US 10,294,499 B2Evolva SA · 2019
- Chalcone synthase2US 7,202,397 B2E. I. Du Pont de Nemours and Company · 2007
- Production of flavonoids by recombinant microorganisms2US 7,807,422 B2The Research Foundation of State University of New York · 2010